Concepedia

Craig R. Fairchild

CR

70

Publications

5.3K

Citations

44

H-Index

1986

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Bristol-Myers Squibb (Germany)

University of the South Pacific

Georgia Institute of Technology

University of Illinois Chicago

Craig R. Fairchild is an author at Bristol-Myers Squibb (United States) specializing in pharmacology, medicine, and drug discovery.

Top concepts

PharmacologyMedicineDrug DiscoveryMedicinal ChemistryNatural SciencesBiochemistryDrug DevelopmentPharmacotherapyTumor BiologyCancer Research

Publications per year

1986–2014

70

Publications

70

BMS-247550: a novel epothilone analog with a mode of action similar to paclitaxel but possessing superior antitumor efficacy.

Francis Y. F. Lee, R. M. Borzilleri, Craig R. Fairchild et al. · PubMed · 2001 · 455 citations

Pharmacotherapy, Tumor Biology, Superior Antitumor Efficacy +17

Expression of anionic glutathione-S-transferase and P-glycoprotein genes in human tissues and tumors.

Jeffrey A. Moscow, Craig R. Fairchild, Mary Madden et al. · PubMed · 1989 · 352 citations

Glycobiology, Pathology, P-glycoprotein Genes +20

Eleutherobin, a New Cytotoxin that Mimics Paclitaxel (Taxol) by Stabilizing Microtubules

Thomas Lindel, Paul R. Jensen, William Fenical et al. · Journal of the American Chemical Society · 1997 · 294 citations

Drug Target, Toxinology, Altmetric Attention Score +21

Stephacidin A and B: Two Structurally Novel, Selective Inhibitors of the Testosterone-Dependent Prostate LNCaP Cells

Jingfang Qian‐Cutrone, Stella Huang, Yue‐Zhong Shu et al. · Journal of the American Chemical Society · 2002 · 221 citations

Secondary Metabolite, Selective Inhibitors, Pharmacotherapy +19

Silvestrol and Episilvestrol, Potential Anticancer Rocaglate Derivatives from <i>Aglaia silvestris</i>

Bang Yeon Hwang, Bao-Ning Su, Heebyung Chai et al. · The Journal of Organic Chemistry · 2004 · 191 citations

Rows per page

1–5 of 70